Iambic Therapeutics Inc. (IAM)
$18.91Close
FLAT
Snapshot
Signal: Score, ATR trend, HiLo flip, Coil, Exhaustion, Topping · Technicals (EMA stack, slope, squeeze, stochastic, MACD-Z, DI+)
Signal: Composite · Performance (Q-Score, Sharpe, Sortino, Calmar, CAGR, drawdown, alpha)
Signal evidence
- Now
- NEUTRAL
Best Combo (today's action, held-out profit factor and family votes) · Regime: Profit factor, Trades · Exhaustion (whether buyers or sellers are stretched today and the latest release)
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company
About
Iambic Therapeutics Inc. (IAM). Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded by Thomas Miller and Fred Manby on October 14, 2019 and is headquartered in San Diego, CA.
SEC filingsCIK 1997038
Profile
SectorTechnology
IndustrySoftware - Application
ExchangeNASDAQ
CountryUS
CEOThomas Miller
IPOOct 15
Employees-
Shares outstanding9.4M
Float-
Free float-
Websiteiambic.ai
Earnings history
Loading earnings…
